<?xml version="1.0" encoding="iso-8859-1" ?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<atom:link href="http://content.karger.com/ProdukteDB/rss.asp?j=ONK" rel="self" type="application/rss+xml" />
<title>Onkologie : Last 20 articles</title>
<link>http://content.karger.com</link>
<description>Last 20 articles published in Onkologie</description>
<language>en</language>
<copyright>Copyright 2009, S.Karger AG</copyright>
<lastBuildDate>Fri, 20 Nov 2009 00:02:18 +0100</lastBuildDate>
<generator>S.Karger AG</generator>
<docs>http://content.karger.com/company/help.asp</docs>
<ttl>20</ttl>
<image>
<title>Onkologie</title>
<url>http://content.karger.com/ProdukteDB/katalogteile/issn/_0378_584X/cover.gif</url>
<link>http://content.karger.com</link>
</image>
<item>
<title>Limited Predictive Value of FDG-PET for Response Assessment in the Preoperative Treatment of Esophageal Cancer: Results of a Prospective Multi-Center Trial (SAKK 75/02)</title>
<link>http://content.karger.com/produktedb/produkte.asp?doi=251842</link>
<guid>http://content.karger.com/produktedb/produkte.asp?doi=251842</guid>
<pubDate>Mon, 09 Nov 2009 00:00:00 +0100</pubDate>
<description>Onkologie 2009;32:1 (DOI:10.1159/000251842)</description>
</item>
<item>
<title>Contents of Forthcoming Issues ˇ Themenvorschau</title>
<link>http://content.karger.com/produktedb/produkte.asp?doi=254844</link>
<guid>http://content.karger.com/produktedb/produkte.asp?doi=254844</guid>
<pubDate>Wed, 28 Oct 2009 00:00:00 +0100</pubDate>
<description>Onkologie 2009;32:700 (DOI:10.1159/000254844)</description>
</item>
<item>
<title>Guidelines for Authors</title>
<link>http://content.karger.com/produktedb/produkte.asp?doi=254843</link>
<guid>http://content.karger.com/produktedb/produkte.asp?doi=254843</guid>
<pubDate>Wed, 28 Oct 2009 00:00:00 +0100</pubDate>
<description>Onkologie 2009;32:699 (DOI:10.1159/000254843)</description>
</item>
<item>
<title>Meetings and Conferences ˇ Tagungen und Kongresse</title>
<link>http://content.karger.com/produktedb/produkte.asp?doi=254838</link>
<guid>http://content.karger.com/produktedb/produkte.asp?doi=254838</guid>
<pubDate>Wed, 28 Oct 2009 00:00:00 +0100</pubDate>
<description>Onkologie 2009;32:696-698 (DOI:10.1159/000254838)</description>
</item>
<item>
<title>PharmaNews ˇ PharmaTicker</title>
<link>http://content.karger.com/produktedb/produkte.asp?doi=254837</link>
<guid>http://content.karger.com/produktedb/produkte.asp?doi=254837</guid>
<pubDate>Wed, 28 Oct 2009 00:00:00 +0100</pubDate>
<description>Onkologie 2009;32:692-695 (DOI:10.1159/000254837)</description>
</item>
<item>
<title>PharmaNews</title>
<link>http://content.karger.com/produktedb/produkte.asp?doi=254835</link>
<guid>http://content.karger.com/produktedb/produkte.asp?doi=254835</guid>
<pubDate>Wed, 28 Oct 2009 00:00:00 +0100</pubDate>
<description>Onkologie 2009;32:691 (DOI:10.1159/000254835)</description>
</item>
<item>
<title>Gemeinsame Jahrestagung 2009 der DGHO, ÖGHO, SGMO und SGH+SSH, Heidelberg / Mannheim, 2. bis 6. Oktober 2009</title>
<link>http://content.karger.com/produktedb/produkte.asp?doi=254833</link>
<guid>http://content.karger.com/produktedb/produkte.asp?doi=254833</guid>
<pubDate>Wed, 28 Oct 2009 00:00:00 +0100</pubDate>
<description>Onkologie 2009;32:688-690 (DOI:10.1159/000254833)</description>
</item>
<item>
<title>Vol. 32, Issue 11, November 2009 / Band 32, Heft 11, November 2009</title>
<link>http://content.karger.com/produktedb/produkte.asp?doi=254831</link>
<guid>http://content.karger.com/produktedb/produkte.asp?doi=254831</guid>
<pubDate>Wed, 28 Oct 2009 00:00:00 +0100</pubDate>
<description>Onkologie 2009;32:618 (DOI:10.1159/000254831)</description>
</item>
<item>
<title>Editorial Board</title>
<link>http://content.karger.com/produktedb/produkte.asp?doi=254830</link>
<guid>http://content.karger.com/produktedb/produkte.asp?doi=254830</guid>
<pubDate>Wed, 28 Oct 2009 00:00:00 +0100</pubDate>
<description>Onkologie 2009;32:617 (DOI:10.1159/000254830)</description>
</item>
<item>
<title>EGFR-TKI Treatment and Surgical Resection for Oligometastatic NSCLC?</title>
<link>http://content.karger.com/produktedb/produkte.asp?doi=246616</link>
<guid>http://content.karger.com/produktedb/produkte.asp?doi=246616</guid>
<pubDate>Tue, 20 Oct 2009 00:00:00 +0100</pubDate>
<description>Onkologie 2009;32:627-628 (DOI:10.1159/000246616)</description>
</item>
<item>
<title>The Importance of Growth Factors and Steroid Hormones in Ovarian Cancer</title>
<link>http://content.karger.com/produktedb/produkte.asp?doi=246764</link>
<guid>http://content.karger.com/produktedb/produkte.asp?doi=246764</guid>
<pubDate>Fri, 16 Oct 2009 00:00:00 +0100</pubDate>
<description>Onkologie 2009;32:623-624 (DOI:10.1159/000246764)</description>
</item>
<item>
<title>Weekly Cetuximab and Gemcitabine plus Cisplatin as Salvage Therapy for Unresectable Non-Small Cell Lung Cancer</title>
<link>http://content.karger.com/produktedb/produkte.asp?doi=242265</link>
<guid>http://content.karger.com/produktedb/produkte.asp?doi=242265</guid>
<pubDate>Fri, 16 Oct 2009 00:00:00 +0100</pubDate>
<description>Onkologie 2009;32:685-686 (DOI:10.1159/000242265)</description>
</item>
<item>
<title>Local Expression of Insulin-Like Growth Factor-I, Insulin-Like Growth Factor-I Receptor, and Estrogen Receptor Alpha in Ovarian Cancer</title>
<link>http://content.karger.com/produktedb/produkte.asp?doi=242253</link>
<guid>http://content.karger.com/produktedb/produkte.asp?doi=242253</guid>
<pubDate>Fri, 16 Oct 2009 00:00:00 +0100</pubDate>
<description>Onkologie 2009;32:638-644 (DOI:10.1159/000242253)</description>
</item>
<item>
<title>Economic Impact of Alternative Adjuvant Chemotherapy Regimens for Stage III Colon Cancer</title>
<link>http://content.karger.com/produktedb/produkte.asp?doi=242252</link>
<guid>http://content.karger.com/produktedb/produkte.asp?doi=242252</guid>
<pubDate>Fri, 16 Oct 2009 00:00:00 +0100</pubDate>
<description>Onkologie 2009;32:647-652 (DOI:10.1159/000242252)</description>
</item>
<item>
<title>A Case of Malignant Abdominal Pain</title>
<link>http://content.karger.com/produktedb/produkte.asp?doi=242251</link>
<guid>http://content.karger.com/produktedb/produkte.asp?doi=242251</guid>
<pubDate>Fri, 16 Oct 2009 00:00:00 +0100</pubDate>
<description>Onkologie 2009;32:666-668 (DOI:10.1159/000242251)</description>
</item>
<item>
<title>Management of Obstructive Uropathy Patients with Advanced Prostate Cancer -- A Systematic Review</title>
<link>http://content.karger.com/produktedb/produkte.asp?doi=242250</link>
<guid>http://content.karger.com/produktedb/produkte.asp?doi=242250</guid>
<pubDate>Fri, 16 Oct 2009 00:00:00 +0100</pubDate>
<description>Onkologie 2009;32:680-684 (DOI:10.1159/000242250)</description>
</item>
<item>
<title>Nitric Oxide Synthase (NOS2/3) Expression in Head and Neck Squamous Cell Carcinomas in Correlation with Clinical Patterns</title>
<link>http://content.karger.com/produktedb/produkte.asp?doi=242233</link>
<guid>http://content.karger.com/produktedb/produkte.asp?doi=242233</guid>
<pubDate>Fri, 16 Oct 2009 00:00:00 +0100</pubDate>
<description>Onkologie 2009;32:655-660 (DOI:10.1159/000242233)</description>
</item>
<item>
<title>Multiple Bulky Cutaneous Plasmacytomas with CNS Relapse without Bone Marrow Involvement during the Course of a Lambda Light Chain Myeloma</title>
<link>http://content.karger.com/produktedb/produkte.asp?doi=242254</link>
<guid>http://content.karger.com/produktedb/produkte.asp?doi=242254</guid>
<pubDate>Tue, 13 Oct 2009 00:00:00 +0100</pubDate>
<description>Onkologie 2009;32:662-664 (DOI:10.1159/000242254)</description>
</item>
<item>
<title>Severe Thrombocytopenia in a Patient with Metastatic Renal Cell Carcinoma</title>
<link>http://content.karger.com/produktedb/produkte.asp?doi=242221</link>
<guid>http://content.karger.com/produktedb/produkte.asp?doi=242221</guid>
<pubDate>Tue, 13 Oct 2009 00:00:00 +0100</pubDate>
<description>Onkologie 2009;32:670-672 (DOI:10.1159/000242221)</description>
</item>
<item>
<title>Down-Staging of EGFR Mutation-Positive Advanced Lung Carcinoma with Gefitinib Followed by Surgical Intervention: Follow-Up of Two Cases</title>
<link>http://content.karger.com/produktedb/produkte.asp?doi=242220</link>
<guid>http://content.karger.com/produktedb/produkte.asp?doi=242220</guid>
<pubDate>Tue, 13 Oct 2009 00:00:00 +0100</pubDate>
<description>Onkologie 2009;32:674-677 (DOI:10.1159/000242220)</description>
</item>
</channel>
</rss>
